Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients

[at noodls] – DUBLIN, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) — Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced … more

View todays social media effects on ASTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Astex is hiring next, click here to view